Targeting hypoxia at the forefront of anticancer immune responses.

@article{Noman2014TargetingHA,
  title={Targeting hypoxia at the forefront of anticancer immune responses.},
  author={Muhammad Zaeem Noman and Salem Chouaib},
  journal={Oncoimmunology},
  year={2014},
  volume={3 12},
  pages={e954463}
}
Hypoxia influences immune checkpoint receptors and their respective ligands. In support, we recently demonstrated that hypoxia selectively upregulates programmed cell death ligand 1 (PD-L1) on myeloid-derived suppressor cells (MDSCs) via hypoxia inducible factor 1 α (HIF-1α) binding to a hypoxia-response element (HRE) in the PD-L1 proximal promoter. Furthermore, blockade of PD-L1 under hypoxic conditions enhanced MDSC-mediated T-cell activation by attenuating MDSC secretion of IL-6 and IL-10. 
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…